mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.01 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
CAY10603 |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |